All lobbying filings

DLA PIPER LLP (US)

Lobbying for INTRA-CELLULAR THERAPIES, INC. · Biopharmaceutical company.

Filing 4th Quarter - Termination

4th Quarter (Oct 1 - Dec 31) 2025 · New York · House · Senate · $50,000.00 income · posted Jan 16, 2026

Official filing document

Bills named in this filing 1

HR 5376
Impacts and Outcomes for Health Career Training Act

Lobbying activity 1

Health Issues

Issues related to drug pricing, Medicare reimbursement, implementation of the Inflation Reduction Act, and mental health. H.R. 5376, Impacts and Outcomes for Health Career Training Act.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.